|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2000-4-28
|
|
pubmed:abstractText |
To establish methodology which rapidly and reliably assesses the effect of an alpha1-adrenoceptor antagonist on peak urine flow rates in men with benign prostatic hyperplasia (BPH). This methodology could then be applied to screening new drugs to treat BPH.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/10718783-1279214,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10718783-1281727,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10718783-1281729,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10718783-1379106,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10718783-1383816,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10718783-7539853,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10718783-7539854,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10718783-7551841,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10718783-7678870,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10718783-8607227,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10718783-9186370,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10718783-9475762,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10718783-9609623
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0306-5251
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
49
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
269-73
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10718783-Adrenergic alpha-1 Receptor Antagonists,
pubmed-meshheading:10718783-Adrenergic alpha-Antagonists,
pubmed-meshheading:10718783-Aged,
pubmed-meshheading:10718783-Cross-Over Studies,
pubmed-meshheading:10718783-Double-Blind Method,
pubmed-meshheading:10718783-Humans,
pubmed-meshheading:10718783-Male,
pubmed-meshheading:10718783-Middle Aged,
pubmed-meshheading:10718783-Prostatic Hyperplasia,
pubmed-meshheading:10718783-Receptors, Adrenergic, alpha-1,
pubmed-meshheading:10718783-Rheology,
pubmed-meshheading:10718783-Urination
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Single dose methodology to assess the influence of an alpha1-adrenoceptor antagonist on uroflowmetric parameters in patients with benign prostatic hyperplasia.
|
|
pubmed:affiliation |
Division of Clinical Pharmacology, Merck and Co., Rahway, NJ 07065, USA. sean_curtis@merck.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
